Loading people...
Juliette Lee is a Vice President at EQT Life Sciences, focusing on venture capital investments within the biotechnology sector. In this position, she manages the end-to-end deal process, including opportunity sourcing, scientific due diligence, and negotiations, while providing post-investment support as a board observer. Before joining EQT, Lee served as an Analyst at 4BIO Capital in London and worked as an Investment Fellow at M Ventures in Amsterdam. Her academic credentials include a doctorate in Medical Sciences from the University of Cambridge and a master's degree in Neuroscience from King's College London. She frequently participates in industry events, recently scheduling an appearance at the 2025 LSX Investival Showcase Europe to discuss post-Series A strategies. Lee's background combines advanced scientific research with venture capital expertise to guide clinical development and regulatory engagement for early-stage life sciences startups.
Juliette Lee is a highly valued Associate at EQT Life Sciences, a prominent global investment organization dedicated to partnering with innovative companies across the life sciences sector. In her role, Juliette is instrumental in identifying, evaluating, and supporting groundbreaking investment opportunities that have the potential to transform healthcare and improve patient outcomes. Her work is critical to EQT Life Sciences' mission of fostering growth and innovation within the biotechnology, pharmaceutical, medical technology, and digital health landscapes.
As an Associate, Juliette's responsibilities are multifaceted and dynamic. She conducts comprehensive market research, performs in-depth due diligence on prospective portfolio companies, and analyzes complex scientific and financial data to assess investment viability. She works closely with senior investment professionals, contributing to deal sourcing, financial modeling, and the strategic development of investment theses. Juliette is often involved in post-investment support, collaborating with portfolio companies to help them achieve their strategic milestones and maximize their impact. Her analytical rigor and keen understanding of scientific advancements are key assets in navigating the intricate world of life sciences investing.
Juliette's investment focus at EQT Life Sciences spans a broad spectrum of the life sciences industry. She is particularly interested in companies that are developing novel therapeutics, cutting-edge diagnostics, innovative medical devices, and transformative digital health solutions. Her expertise extends to understanding the regulatory pathways, clinical development processes, and commercialization strategies crucial for success in these areas. Whether it is an early-stage biotech startup with a promising drug candidate or a growth-stage medtech company expanding its market reach, Juliette seeks out opportunities that align with EQT Life Sciences' commitment to backing companies with strong scientific foundations and significant market potential.
While specific details of her career background are not publicly detailed, professionals in Juliette's position typically bring a strong foundation in finance, science, or a combination thereof. Many Associates at leading life sciences investment firms possess advanced degrees in scientific disciplines, prior experience in healthcare consulting, investment banking, or roles within pharmaceutical or biotechnology companies. This diverse background equips them with the unique perspective needed to bridge the gap between scientific innovation and financial strategy. Juliette's contributions help EQT Life Sciences maintain its position as a leading investor in the global life sciences ecosystem, driving capital towards solutions that address critical unmet medical needs. Her dedication to identifying and nurturing the next generation of life sciences leaders underscores her commitment to advancing human health.
Juliette Lee is an Associate at EQT Life Sciences, a global investment organization focused on the life sciences sector. She plays a crucial role in identifying and evaluating innovative investment opportunities in healthcare and biotechnology.
Juliette Lee invests in a broad range of life sciences companies, including those developing novel therapeutics, diagnostics, medical devices, and digital health solutions. Her focus is on early-stage to growth-stage companies with strong scientific foundations and significant market potential.
Juliette Lee works as an Associate at EQT Life Sciences, a leading global investment firm dedicated to the life sciences industry.
